FAQ

Resectable Pancreatic Carcinoma

Known as: Resectable Pancreatic Cancer, Pancreatic Carcinoma, Resectable, Resectable Pancreas Carcinoma 
Carcinoma of the pancreas amenable to surgical removal.

Topic mentions per year

Topic mentions per year

1998-2017
051019982017

Related topics

Related topics

8 relations
Epithelial CellsEpitheliumExocrine pancreasGastrointestinal system
(More)

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Resectable Pancreatic Carcinoma
cancer cell
Pancreas
Gastrointestinal system
Epithelial Cells
Epithelium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
In pancreatic cancer, genetic markers to aid clinical decision making are still lacking. The present study was designed to… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
BACKGROUND Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. The high risk of recurrence following surgical… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2010
2010
Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
Pancreatic cancer is one of the most deadly cancers, and serum carbohydrate antigen 19-9 (CA19-9) level has been reported to be a… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA; Gastrointestinal Oncology Program, Irvine Medical Center… (More)
Is this relevant?
2009
2009
Resectable Pancreatic Cancer: Who Really Benefits From Resection?
The 1-year disease-related mortality after resection for pancreatic cancer is approximately 30%. This study examined potential… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
Pancreatic cancer is the fourth leading cause of cancer-related death in Western countries with a poor prognosis (5-year survival… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin
Survival after surgery for pancreas cancer remains low. This improves with adjuvant chemotherapy, but up to 30% patients do not… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma
We report the results of a multi-institutional phase II trial that used preoperative full-dose gemcitabine and radiotherapy for… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2005
2005
Prognostic Implication of Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer
The survival curve of patients who undergo surgical resection of pancreatic cancer displays a steep decline within 1 year and a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2005
2005
Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer
Focal adhesion kinase (FAK) is a non-receptor, cytoplasmic protein tyrosine kinase that is involved in the regulation of cellular… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?